Phytocannabinoids in the treatment of cancer

A combination of the phytocannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) together with temozolomide is disclosed for use in the treatment of a glioma, wherein the THC and CBD are present in a ratio of approximately 1:1 (THC:CBD) and preferably wherein the dose level of the phytocannab...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Luciano De Petrocellis, Angelo Antonio Izzo, Aniello Schiano Moriello, Manuel Guzman Pastor, Lesley Ann Ford, Colin Stott, Daniela Parolaro, Ruth Alexandra Ross, Stephen Wright, Sharon Anavi-Goffer, Sofia Torres, Paola Massi, Francesca Borelli, Vincenzo Di Marzo, Etienne De Meijer, Gabriella Aviello, Alessia Ligresti, Guillermo Velasco, Mar Lorente, Alan Sutton, David Potter, Geoffrey Guy, Tetsuro Kikuchi
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A combination of the phytocannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD) together with temozolomide is disclosed for use in the treatment of a glioma, wherein the THC and CBD are present in a ratio of approximately 1:1 (THC:CBD) and preferably wherein the dose level of the phytocannabinoids and/or the temozolomide is sub-effective if used alone